发明名称 |
METHODS AND COMPOSITIONS FOR CANCER THERAPY AND FOR PROGNOSTICATING RESPONSES TO CANCER THERAPY |
摘要 |
A method for determining the efficacy of a therapeutic agent, in vitro, for a cancer expressing or overexpressing an oncogene product is described. The method is particularly useful for determining the efficacy of therapeutic agents that have a binding affinity for cancer that express HER-2/neu. N24, N28 and N29 monoclonal antibodies are described which have been identified by this method. One or more of these antibodies can be used as a therapeutic agent in the treatment of breast, stomach, ovarian or salivary cancers.
|
申请公布号 |
CA2096417(C) |
申请公布日期 |
2000.10.10 |
申请号 |
CA19922096417 |
申请日期 |
1992.08.21 |
申请人 |
|
发明人 |
BACUS, SARAH S.;YARDEN, YOSEF;SELA, MICHAEL |
分类号 |
A61K38/00;A61K47/48;C07K16/30;C07K16/32;G01N33/50;(IPC1-7):C12P21/08;C12Q1/02;A61K39/395;G01N33/566;G01N33/577 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|